Syschem (India)

{
  "main_header": {
    "sid": 161419,
    "name": "Syschem (India)",
    "stock_name": "Syschem (India)",
    "full_name": "Syschem (India) Ltd",
    "name_url": "stocks-analysis/syschem-india",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "52.45",
    "chg": 0.24,
    "chgp": "0.46%",
    "dir": 1,
    "prev_price": "52.21",
    "mcapval": "230.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531173,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE121D01036",
    "curr_date": "Feb 09",
    "curr_time": "",
    "bse_nse_vol": "35.34 k",
    "exc_status": "Active",
    "traded_date": "Feb 09, 2026",
    "traded_date_str": "2026 02 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/syschem-india-161419-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Syschem Gains 11.39%: 5 Key Factors Driving This Week’s Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syschem-gains-1139-5-key-factors-driving-this-weeks-volatility-3827500",
        "imagepath": "",
        "date": "2026-02-08 15:01:20",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Strong Q3 results and upgrade to Buy rating</p>\n                    <p><strong>3 Feb:</strong> Formation of Death Cross and downgrade to Hold</p>\n                    <p><strong>3 Feb:</strong> Valuation shifts to very expensive then fair</p>\n                    <p><strong>4 Feb:</strong> Mixed technical signals and cautious outlook</p>\n                    <p><strong>6 Feb:</strong> Week closes at Rs.52.21 (+11.39%) outperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.46.87</div></div>\n                    <div class=\"stat-i..."
      },
      {
        "title": "Syschem (India) Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syschem-india-ltd-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-3819888",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SyschemIndiaLtd_mojoScore_3819888.png",
        "date": "2026-02-04 08:09:09",
        "description": "Syschem (India) Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 3 February 2026. This adjustment follows a comprehensive reassessment across four key parameters: quality, valuation, financial trend, and technicals. Despite robust financial performance and market-beating returns, evolving technical indicators and a shift to fair valuation have tempered the outlook, prompting a more cautious stance."
      },
      {
        "title": "Syschem (India) Ltd Forms Death Cross, Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syschem-india-ltd-forms-death-cross-signalling-potential-bearish-trend-3818880",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SyschemIndiaLtd_dealthcross_3818880.png",
        "date": "2026-02-03 18:00:24",
        "description": "Syschem (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a deterioration in the stock’s medium to long-term momentum."
      },
      {
        "title": "Syschem (India) Ltd Valuation Shifts Signal Heightened Price Attractiveness Amid Sector Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syschem-india-ltd-valuation-shifts-signal-heightened-price-attractiveness-amid-sector-dynamics-3817040",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SyschemIndiaLtd_valuationdot_3817040.png",
        "date": "2026-02-03 08:00:16",
        "description": "Syschem (India) Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, driven primarily by its elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios. This change reflects evolving market perceptions and invites a closer examination of the company’s price attractiveness relative to its historical averages and peer group within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Why is Syschem (India) Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-syschem-india-ltd-fallingrising-3816949",
        "imagepath": "",
        "date": "2026-02-03 01:13:34",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Robust Quarterly Results Fuel Investor Optimism</strong></p>\n<p>Syschem (India) Ltd’s recent surge can be primarily attributed to its outstanding financial performance reported for the quarter ending December 2025. The company posted a remarkable net profit growth of 734%, underscoring a strong operational turnaround. Key metrics such as PBDIT reaching a quarterly high of ₹5.96 crores and an operating profit to net sales ratio peaking at 4.21% highlight improved profitability and operational efficiency. Additionally, the company’s profit before tax excluding other income stood at ₹4.97 crores, marking the highest level in recent quarters.</p>\n<p>This consistent positive momentum is further evidenced by the company declaring profits for five consecutive quarters, signalling sustained business..."
      },
      {
        "title": "Are Syschem (India) Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-syschem-india-ltd-latest-results-good-or-bad-3816829",
        "imagepath": "",
        "date": "2026-02-02 19:13:21",
        "description": "Syschem (India) Ltd's latest financial results for Q3 FY26 reveal a strong operational performance characterized by significant revenue and profit growth. The company reported net sales of ₹141.50 crores, reflecting an 81.97% increase year-on-year compared to ₹77.76 crores in Q3 FY25. This growth follows a quarter-on-quarter rise of 36.58% from ₹103.60 crores in Q2 FY26, indicating a robust recovery after a brief decline in the previous quarter.\n\nNet profit for the same period reached ₹4.17 crores, marking a remarkable 734% increase year-on-year from ₹0.50 crores in Q3 FY25, and a sequential improvement of 119.47% from ₹1.90 crores in Q2 FY26. The operating margin also showed significant enhancement, reaching an all-time high of 4.21%, compared to 1.54% in the same quarter last year, reflecting improved operational efficiency and cost management.\n\nThe company's financial metrics indicate a strong trajectory..."
      },
      {
        "title": "Syschem (India) Q3 FY26: Strong Profit Surge Masks Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/syschem-india-q3-fy26-strong-profit-surge-masks-valuation-concerns-3816813",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SyschemIndia_quaterlyResult_3816813.png",
        "date": "2026-02-02 18:15:40",
        "description": "Syschem (India) Ltd., a micro-cap pharmaceutical API manufacturer, delivered a remarkable turnaround in Q3 FY26 with net profit surging to ₹4.17 crores—a sequential jump of 119.47% from Q2's ₹1.90 crores and an impressive 734% year-on-year leap from ₹0.50 crores in Q3 FY25. The company's stock responded enthusiastically, rallying 7.00% on February 02, 2026 to close at ₹51.99, though the shares remain 16.15% below their 52-week high of ₹62.00."
      },
      {
        "title": "Syschem (India) Ltd Upgraded to Buy on Strong Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syschem-india-ltd-upgraded-to-buy-on-strong-financial-and-technical-signals-3815682",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SyschemIndiaLtd_mojoScore_3815682.png",
        "date": "2026-02-02 08:09:25",
        "description": "Syschem (India) Ltd has seen its investment rating upgraded from Hold to Buy, reflecting a marked improvement across key parameters including quality, valuation, financial trends, and technical indicators. This upgrade, effective from 1 February 2026, follows a period of robust financial performance and evolving market sentiment that positions the company favourably within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Syschem (India) Ltd Downgraded to Hold Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syschem-india-ltd-downgraded-to-hold-amid-mixed-financial-and-technical-signals-3806765",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SyschemIndiaLtd_mojoScore_3806765.png",
        "date": "2026-01-28 08:04:47",
        "description": "Syschem (India) Ltd’s investment rating has been downgraded from Buy to Hold as of 27 Jan 2026, reflecting a nuanced reassessment of its technical indicators, valuation metrics, financial trends, and overall quality. Despite impressive recent financial performance, the stock’s technical outlook and valuation premium have prompted a more cautious stance among analysts."
      }
    ],
    "total": 107,
    "sid": "161419",
    "stock_news_url": "https://www.marketsmojo.com/news/syschem-india-161419"
  },
  "announcements": [
    {
      "caption": "General Update_ Newspaper Advertisement As Per Regulation 47(3) Schedule Iii Of SEBI (Listing Obligations And Disclosure Requirements) 2015",
      "datetime": "03-Feb-2026",
      "details": "Pursuant to Reg 47(3) schedule III of SEBI (Listing Obligations and Disclosure requirements) 2015: Newspaper advertisement for unaudited result for the quarter and nine months ended 31st December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
      "datetime": "02-Feb-2026",
      "details": "Outcome of the Board meeting and declaration of results for the quarter and nine months ending 31st March 2025.",
      "source": "BSE"
    },
    {
      "caption": "Investors Presentation",
      "datetime": "02-Feb-2026",
      "details": "Investors Presentation",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Syschem (India) Ltd has announced <strong>10:1</strong> stock split, ex-date: 12 Dec 14",
          "dt": "2014-12-12",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Syschem (India) Ltd has announced <strong>1:4</strong> rights issue, ex-date: 28 Sep 23",
          "dt": "2023-09-28",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Syschem Gains 11.39%: 5 Key Factors Driving This Week’s Volatility

2026-02-08 15:01:20

Key Events This Week

2 Feb: Strong Q3 results and upgrade to Buy rating

3 Feb: Formation of Death Cross and downgrade to Hold

3 Feb: Valuation shifts to very expensive then fair

4 Feb: Mixed technical signals and cautious outlook

6 Feb: Week closes at Rs.52.21 (+11.39%) outperforming Sensex

Week Open

Rs.46.87

Read full news article

Syschem (India) Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals

2026-02-04 08:09:09

Syschem (India) Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 3 February 2026. This adjustment follows a comprehensive reassessment across four key parameters: quality, valuation, financial trend, and technicals. Despite robust financial performance and market-beating returns, evolving technical indicators and a shift to fair valuation have tempered the outlook, prompting a more cautious stance.

Read full news article

Syschem (India) Ltd Forms Death Cross, Signalling Potential Bearish Trend

2026-02-03 18:00:24

Syschem (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a deterioration in the stock’s medium to long-term momentum.

Read full news article

Syschem (India) Ltd Valuation Shifts Signal Heightened Price Attractiveness Amid Sector Dynamics

2026-02-03 08:00:16

Syschem (India) Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, driven primarily by its elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios. This change reflects evolving market perceptions and invites a closer examination of the company’s price attractiveness relative to its historical averages and peer group within the Pharmaceuticals & Biotechnology sector.

Read full news article

Why is Syschem (India) Ltd falling/rising?

2026-02-03 01:13:34

Robust Quarterly Results Fuel Investor Optimism

Syschem (India) Ltd’s recent surge can be primarily attributed to its outstanding financial performance reported for the quarter ending December 2025. The company posted a remarkable net profit growth of 734%, underscoring a strong operational turnaround. Key metrics such as PBDIT reaching a quarterly high of ₹5.96 crores and an operating profit to net sales ratio peaking at 4.21% highlight improved profitability and operational efficiency. Additionally, the company’s profit before tax excluding other income stood at ₹4.97 crores, marking the highest level in recent quarters.

This consistent positive momentum is further evidenced by the company declaring profits for five consecutive quarters, signalling sustained business...

Read full news article

Are Syschem (India) Ltd latest results good or bad?

2026-02-02 19:13:21

Syschem (India) Ltd's latest financial results for Q3 FY26 reveal a strong operational performance characterized by significant revenue and profit growth. The company reported net sales of ₹141.50 crores, reflecting an 81.97% increase year-on-year compared to ₹77.76 crores in Q3 FY25. This growth follows a quarter-on-quarter rise of 36.58% from ₹103.60 crores in Q2 FY26, indicating a robust recovery after a brief decline in the previous quarter. Net profit for the same period reached ₹4.17 crores, marking a remarkable 734% increase year-on-year from ₹0.50 crores in Q3 FY25, and a sequential improvement of 119.47% from ₹1.90 crores in Q2 FY26. The operating margin also showed significant enhancement, reaching an all-time high of 4.21%, compared to 1.54% in the same quarter last year, reflecting improved operational efficiency and cost management. The company's financial metrics indicate a strong trajectory...

Read full news article

Syschem (India) Q3 FY26: Strong Profit Surge Masks Valuation Concerns

2026-02-02 18:15:40

Syschem (India) Ltd., a micro-cap pharmaceutical API manufacturer, delivered a remarkable turnaround in Q3 FY26 with net profit surging to ₹4.17 crores—a sequential jump of 119.47% from Q2's ₹1.90 crores and an impressive 734% year-on-year leap from ₹0.50 crores in Q3 FY25. The company's stock responded enthusiastically, rallying 7.00% on February 02, 2026 to close at ₹51.99, though the shares remain 16.15% below their 52-week high of ₹62.00.

Read full news article

Syschem (India) Ltd Upgraded to Buy on Strong Financial and Technical Signals

2026-02-02 08:09:25

Syschem (India) Ltd has seen its investment rating upgraded from Hold to Buy, reflecting a marked improvement across key parameters including quality, valuation, financial trends, and technical indicators. This upgrade, effective from 1 February 2026, follows a period of robust financial performance and evolving market sentiment that positions the company favourably within the Pharmaceuticals & Biotechnology sector.

Read full news article

Syschem (India) Ltd Downgraded to Hold Amid Mixed Financial and Technical Signals

2026-01-28 08:04:47

Syschem (India) Ltd’s investment rating has been downgraded from Buy to Hold as of 27 Jan 2026, reflecting a nuanced reassessment of its technical indicators, valuation metrics, financial trends, and overall quality. Despite impressive recent financial performance, the stock’s technical outlook and valuation premium have prompted a more cautious stance among analysts.

Read full news article

View All News